[ad_1]
1.3 billion in the next few days. The largest vaccination campaign in the world should begin in a country with a population of.
Indian Prime Minister Narendra Modi wrote on Twitter that the approval of the vaccines is “a crucial turning point in strengthening the courageous fight” that “accelerates our path to a healthier nation without COVID.”
India ranks second in the world in terms of the number of confirmed cases of COVID-19 infection, with 10.3 million infections in the country. people. Almost 150,000 people died.
The country’s government has already held national exercises before the launch of the mass vaccination program, with about 96,000 people trained to be vaccinated. health system workers.
The World Health Organization has already welcomed this message from India.
Skepticism about vaccines
New vaccines in India, as in other countries, have been approved not without fear of their safety. Recently, 18 thousand. A population survey revealed that 69 percent. people will not rush to get vaccinated.
“At first I was very happy with the vaccine, but not anymore because I don’t trust it. They will not vaccinate me, “Vijaya Dasas, a 58-year-old banker, told AFP on Sunday.
“No vaccine is 100 percent effective, so what is the guarantee that I will not get a coronavirus when I get vaccinated?” Said Suman Saurabh, a 48-year-old salesman.
Anand Krishnan, professor of medicine at the All-Indian Institute of Medical Sciences in New Delhi, believes the government should release more data on vaccine trials.
“They have to publish the results of the tests and allow the researchers to draw their own conclusions, so there will be much less doubt about the vaccines,” he told AFP.
Both doses of the two vaccines must be administered. They can be transported and stored under normal conditions in refrigerators.
The world’s largest vaccine company, Serum Institute of India, announces a monthly production of 50 to 60 million. vaccines developed by AstraZeneca and the University of Oxford. Following the announcement of the approval of the vaccines, their director, Adaras Poonawalla, said on Twitter that the vaccines would be “ready for use in the coming weeks.”
Bharat Biotech has yet to complete Phase III trials of the vaccine, but the main drug controller, VGSomani, said the company-developed vaccine has been allowed limited use “in the public interest with a series of clinical trials of caution to increase vaccination options, especially for mutant strains. ” cases’.
During a press conference, the ombudsman also told reporters that his authority “would never approve of anything if there was at least the slightest concern for safety.”
“The vaccines are 100 percent safe,” he said, adding that side effects such as “low fever, pain or allergy are common to every vaccine.”
them | See also: | right}
[ad_2]
